The final report of post-marketing surveillance for cetuximab in colorectal cancer in Japan

被引：0
|
作者：
Yamaguchi, K.
Satoh, T.
Watanabe, T.
Ishiguro, M.
Maruyama, K.
Seriu, T.
Miki, T.
Ito, H.
Sugihara, K.
Sakata, Y.
机构：
[1] Saitama Canc Ctr, Saitama, Japan
[2] Kinki Univ, Sch Med, Osaka 589, Japan
[3] Teikyo Univ, Sch Med, Dept Surg, Tokyo 173, Japan
[4] Tokyo Med & Dent Univ, Grad Sch, Dept Surg Oncol, Tokyo, Japan
[5] Bristol Myers KK, Tokyo, Japan
[6] Merck Serono, Tokyo, Japan
[7] Misawa Municipal Hosp, Misawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
590
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Post-marketing surveillance of all patients treated with sorafenib for unresectable DTC in Japan: Interim report
    Tahara, Makoto
    Sugitani, Iwao
    Ito, Yasuhiro
    Okayama, Yutaka
    Kawakami, Yoshiko
    Sunaya, Toshiyuki
    Sakaguchi, Toshiaki
    Minami, Hironobu
    Imai, Tsuneo
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan
    Hiraizumi, Kenji
    Honda, Chikara
    Watanabe, Ayu
    Nakao, Takafumi
    Midorikawa, Shuichi
    Abe, Hiromi
    Matsui, Nobuki
    Yamamoto, Tsunehisa
    Sakamoto, Takahiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, : 932 - 943
  • [33] Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients
    Boku, Narikazu
    Sugihara, Kenichi
    Kitagawa, Yuko
    Hatake, Kiyohiko
    Gemma, Akihiko
    Yamazaki, Naoya
    Muro, Kei
    Hamaguchi, Tetsuya
    Yoshino, Takayuki
    Yana, Ikuo
    Ueno, Hiroshi
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (03) : 214 - 223
  • [34] Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson's disease: Final report of a post-marketing surveillance study in Japan
    Takahashi, Makio
    Ito, Satoru
    Tsuji, Yukie
    Horiguchi, Shuji
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 443
  • [35] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [36] POST-MARKETING SURVEILLANCE OF NEW MEDICINES
    SMITHELLS, RW
    BRITISH MEDICAL JOURNAL, 1977, 2 (6096): : 1218 - 1218
  • [37] POST-MARKETING SURVEILLANCE BY DRUG MANUFACTURERS
    不详
    LANCET, 1988, 2 (8617): : 977 - 977
  • [38] Optimization of the post-marketing surveillance procedure
    Kalle, Parminder
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (02) : 125 - 127
  • [39] POST-MARKETING SURVEILLANCE - DRUG EPIDEMIOLOGY
    BORDEN, EK
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (06) : 401 - 407
  • [40] Post-marketing surveillance of novel foods
    Warner, JO
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2002, 13 (06) : 385 - 385
12345